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Medical Marijuana: An Overview of Select
Resources
THERESE A. CLARKE ARADO AND ANNIE MENTKOWSKI*
The following annotated bibliography provides information in a number of areas. The state laws related to legalizing medical marijuana in effect as of January 2015 are summarized. In addition to the statute summaries, annotations of select articles are provided. The greatest portion of materials annotated involves federalism discussions and employment related
issues. Also included, but to a much lesser extent are family law, transportation, and attorney ethics. Additionally, a few articles on state regulatory
power and other topics are included. As this bibliography was being created, the U.S. House of Representatives and Senate introduced legislation to
reclassify marijuana within the Controlled Substances Act. Those bills are
referenced in a section of the bibliography. At the end of the document
there are lists of recent newspaper coverage of the medical marijuana laws
and debates in the United States. The creators of this bibliography did not
attempt to cover the breadth of information available on this topic. These
resources are meant to provide a broad picture of the medical marijuana
discussion at this time, along with some history of the topic. There is significantly more literature available on medical marijuana and the various
legal issues surrounding it. However, this bibliography will give researchers a good start on compiling relevant materials for further study.
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STATUTES
In this section a summary of all states currently with medical marijuana laws is provided. Illinois is listed first as the focus of the symposium is
the newly enacted medical marijuana law in Illinois.
ILLINOIS
The Compassionate Use of Medical Cannabis Pilot Program Act, 410 ILL.
COMP. STAT. ANN. 130/1-130/199 (West, Westlaw through P.A. 981125 of the 2014 Reg. Sess.).
Under the statute, a four-year pilot program has been established
where a registered qualifying patient may possess and use medical marijuana. A qualifying patient is a person who has been diagnosed by a physician
as having a debilitating medical condition, and has obtained a written certification from his/her physician, and has followed all the procedures to become registered with the Department of Public Health.
Possession: 2½ ounces
Homegrown: Prohibited
Dispensaries: Yes
Illnesses: Cancer, glaucoma, HIV/AIDS, hepatitis C, amyotrophic lateral sclerosis, Crohn’s disease, Alzheimer’s disease, cachexia, muscular
dystrophy, severe fibromyalgia, spinal cord disease, including but not limited to arachnoiditis, Tarlov cysts, hydromyelia, syringomyelia, rheumatoid
arthritis, fibrous dysplasia, spinal cord injury, traumatic brain injury and
post-concussion syndrome, multiple sclerosis, Arnold-Chiari malformation,
spinocerebellar ataxia (SCA), Parkinson’s, Tourette’s, myoclonus, dystonia,
reflex sympathetic dystrophy, RSD (complex regional pain syndromes type
I), causalgia, CRPS (complex regional pain syndromes type II), neurofibromatosis, chronic inflammatory demyelinating polyneuropathy, Sjogren’s
syndrome, lupus, interstitial cystitis, myasthenia gravis, hydrocephalus,
nail-patella syndrome, residual limb pain, or the treatment of these conditions or any other debilitating medical condition or its treatment that is added by the Department of Public Health.
Caregivers: Must be at least twenty-one years of age, agree to assist
with a patient’s medical use of marijuana, not convicted of an excluded
offense, and may not assist more than one registered qualifying patient at a
time.
Agency Website:
http://www2.illinois.gov/gov/mcpp/Pages/default.aspx
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ALASKA
Medical Uses of Marijuana for Persons Suffering from Debilitating Medical
Conditions Act, ALASKA STAT. §§ 17.37.010-17.37.080 (West,
Westlaw through Ch. 116 (End) of the 2014 2d Reg. Sess.).
Under the statute, patients who possess a Registry Identification Card
for Medical Use of Marijuana may use, possess, and cultivate marijuana for
personal use. The Registry is maintained by the Department of Health and
Social Services. To be eligible for a card, patients must be placed on the
Registry. This requires a signed statement from the patient’s physician stating that the patient has been diagnosed with a debilitating medical condition
and that “the physician has concluded that the patient might benefit from
the medical use of marijuana.”
Possession: One ounce of usable marijuana.
Homegrown: Six marijuana plants, with no more than three mature
and flowering plants producing usable marijuana at any one time.
Dispensaries: No
Illnesses: Cancer, glaucoma, HIV/AIDS, cachexia, severe pain, severe
nausea, seizures, epilepsy, multiple sclerosis, or any other condition approved by the Department.
Caregivers: Must be at least twenty-one years old, have no felony
convictions for offenses related to controlled substances, and he/she must
be listed by the patient as either the primary caregiver or an alternate caregiver.
Agency Website:
http://dhss.alaska.gov/dph/VitalStats/Pages/marijuana.aspx
ARIZONA
Arizona Medical Marijuana Act, ARIZ. REV. STAT. ANN. §§ 36-2801
to -2819 (West, Westlaw through the Second Regular and Second Special
Sessions of the Fifty-First Legislature).
Under the statute, a qualifying patient and a designated caretaker may
possess or cultivate the requisite amount of marijuana so long as they have
properly joined the Arizona Department of Health Services registry. To be
considered a qualifying patient, a person must obtain a written diagnosis for
a debilitating medical condition from his/her physician. In addition, the law
also recognizes “visiting qualifying patient[s].” These are people with valid
medical recommendations from other medical marijuana states. However,
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the statute does not permit the cultivation of marijuana within twenty-five
miles of a state-licensed dispensary.
Possession: 2 ½ ounces of usable marijuana.
Homegrown: Twelve marijuana plants contained in an enclosed,
locked facility.
Dispensaries: No
Illnesses: Cancer, glaucoma, HIV/AIDS, hepatitis C, amyotrophic lateral sclerosis, Crohn’s Disease, Alzheimer’s Disease, chronic or debilitating
disease or medical condition or its treatment that produces one or more of
the following: cachexia or wasting syndrome, severe and chronic pain, severe nausea, seizures, severe and persistent muscle spasms, including those
characteristic of multiple sclerosis, and any other medical condition or its
treatment added by the Department.
Caregivers: Must be at least twenty-one years old, have agreed to assist with patient’s use, have no excluded felony offense convictions, and
assists five or less qualifying patients.
Agency Website: http://azdhs.gov/preparedness/medical-marijuana/
CALIFORNIA
Medical Marijuana Program, CAL. HEALTH & SAFETY CODE §§ 11362.71136.9 (West, Westlaw through Current with urgency legislation
through Ch. 931 of 2014 Reg. Sess.).
Under the statute, eligible patients may possess and cultivate marijuana. Eligible patients are seriously ill Californians whose physicians have
deemed marijuana to be an appropriate treatment. To be eligible, patients
must present their physicians’ written or oral recommendation. In addition,
California’s Department of Public Health administers a registry, but it is
voluntary.
Possession: Eight ounces (or more if doctor recommended).
Homegrown: Six mature plants or twelve immature plants.
Dispensaries: Yes
Illnesses: AIDS, anorexia, arthritis, cachexia, cancer, chronic pain,
glaucoma, migraine, persistent muscle spasms, including, but not limited to,
spasms associated with multiple sclerosis, seizures (including seizures associated with epilepsy), severe nausea, and any other chronic or persistent
medical symptom that either substantially limits the ability of the person to
conduct one or more major life activity as defined in the Americans with
Disabilities Act of 1990, or if not stopped may cause serious harm to the
patient’s safety or physical or mental health.
Caregivers: At least eighteen-years old (unless the primary caregiver
is the parent of a minor who is a qualified patient or a person with an identi-
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fication card, or is a person otherwise entitled to make medical decisions
under state law), designated by a qualified patient or by a person with an
identification card, who has consistently assumed responsibility for the
housing, health, or safety of that patient or person.
Agency Website:
http://www.cdph.ca.gov/programs/mmp/pages/default.aspx
COLORADO
Medical use of marijuana by persons diagnosed with debilitating medical
conditions—unlawful acts—penalty—medical marijuana program
cash fund, COLO. REV. STAT. ANN. § 18 to 18-406.3 (West, Westlaw
through the Second Reg. Sess. of the Sixty-Ninth Gen. Assemb.).

COLO. CONST. art. XVIII, § 14.
Under Article XVIII and the statute, any patient or primary caregiver
in lawful possession of a registry identification card may engage in or assist
in the medical use of marijuana. To obtain a registry identification card a
patient must reside in Colorado and complete the application process. Patients who do not join the registry and are arrested for possession or cultivation of marijuana may argue an “affirmative defense . . . [of] medical necessity.”
Possession: Two ounces of usable marijuana.
Homegrown: Six plants.
Dispensaries: Yes
Illnesses: Cancer, glaucoma, HIV/AIDS, cachexia, persistent muscle
spasms, seizures, severe nausea, and severe pain.
Caregivers: Must be at least eighteen-years old, must not be the patient or the patient’s physician, must have significant responsibility for
managing the well-being of a patient who has a debilitating medical condition, and must not have a primary caregiver of his/her own. May register
with the Voluntary Caregivers Registry.
Agency Website:
https://www.colorado.gov/pacific/cdphe/medicalmarijuana
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CONNECTICUT
Palliative Use of Marijuana, CONN. GEN. STAT. ANN. §§21a-408 to 21a408q (West, Westlaw through the 2014 Feb. Reg. Sess.).
Under the statute, a patient must obtain written certification from
his/her physician and register with the Department of Consumer Protection.
To be a qualifying patient, he/she must be at least eighteen-years old, a resident of Connecticut, and be diagnosed by a physician as having a debilitating medical condition. This does not include inmates at correctional institutions.
Possession: The combined amount of marijuana possessed by the
qualifying patient and the caregiver may not exceed an amount of usable
marijuana reasonably necessary to ensure uninterrupted availability for one
month. This amount is determined by the Department of Consumer Protection.
Homegrown: Prohibited
Dispensaries: Yes
Illnesses: Cancer, glaucoma, AIDS/HIV, Parkinson’s disease, multiple sclerosis, damage to the nervous tissue of the spinal cord with objective
neurological indication of intractable, spasticity, epilepsy, cachexia, wasting syndrome, Crohn’s disease, post-traumatic stress disorder, any medical
condition, medical treatment or disease approved by the Department of
Consumer Protection.
Caregivers: Must be eighteen years old and have agreed to undertake
responsibility for managing the well-being of the qualifying patient with
respect to the palliative use of marijuana.
Agency Website:
http://www.ct.gov/dcp/cwp/view.asp?a=4287&q=503670&dcpNav=|&
dcpNav_GID=2109
DELAWARE
The Delaware Medical Marijuana Act, DEL. CODE ANN. tit. 16, §§ 4901a4926a (West, Westlaw through 79 laws 2014).
Under the statute, medical use of marijuana is permitted with a doctor’s recommendation. Qualifying patients must be eighteen years old and
they must send their doctor’s written documentation to the state Department
of Health and Social Services. The department will then issue a mandatory
I.D. card. The statute also recognizes qualifying patients from other states.
Qualifying patients who do not have an I.D. card may raise an affirmative
defense motion to dismiss marijuana possession charges.
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Possession: Six ounces of usable marijuana.
Homegrown: Home cultivation is prohibited; only licensed compassion centers may cultivate marijuana.
Dispensaries: Yes
Illnesses: cancer, multiple sclerosis, HIV/AIDS, hepatitis C, ALS,
Alzheimer’s disease, post-traumatic stress disorder, conditions that cause
severe, debilitating pain, wasting syndrome, intractable nausea, and seizures.
Caregivers: Must be at least twenty-one years old and have no felony
convictions for violent crimes or drug crimes (state and federal). S/he is
permitted to assist up to five patients at a time.
Agency Website:
http://dhss.delaware.gov/dph/hsp/medmarhome.html
DISTRICT OF COLUMBIA
Use of Marijuana for Medical Treatment, D.C. CODE §§ 7-1671.01 to71671.13 (West, Westlaw through Nov. 25, 2014).
Under the statute, a qualifying patient or qualifying caretaker may possess and administer medical marijuana. They may also possess and use paraphernalia, only for treatment of a qualifying medical condition or the side
effects of a qualifying medical treatment if they have obtained a written and
signed recommendation from his/her physician and registered with the
mayor.
Possession: Two ounces
Homegrown: Home cultivation is prohibited.
Dispensaries: Yes
Illnesses: Cancer, HIV/AIDS, glaucoma, multiple sclerosis and other
muscle spasticity disorders, and any other condition that is “(i) [c]hronic or
long-lasting; (ii) [d]ebilitating; (iii) [a] serious medical condition for which
the use of medical marijuana is beneficial.”
Caregivers: Must be at least eighteen years old, registered with the
Department, and cannot serve more than one qualified patient at a time.
Agency
Website:
http://doh.dc.gov/service/medical-marijuanaprogram
HAWAII
Medical Use of Marijuana, HAW. REV. STAT. §§ 329-121 to329-128
(West, Westlaw through 2014 Reg. Sess.).
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Under the statute, a qualifying patient is permitted the medical use of
marijuana if he/she has been diagnosed with a debilitating medical condition by a physician, and the physician has certified in writing that, in the
physician's professional opinion, the potential benefits of the medical use of
marijuana would likely outweigh the health risks for the particular qualifying patient. Qualifying patients and caregivers must be registered with the
Department of Health.
Possession: Four ounces
Homegrown: Seven plants (mature or immature).
Dispensaries: Yes
Illnesses: Cachexia, cancer, chronic pain, Crohn’s disease, epilepsy
and other conditions characterized by seizures, glaucoma, HIV/AIDS, multiple sclerosis and other muscle spasticity disorders, nausea (other conditions subject to state approval).
Caregivers: “Primary caregiver” means a person who is at least eighteen years old, other than the qualifying patient and the qualifying patient’s
physician, who has agreed to undertake responsibility for managing the
well-being of the qualifying patient with respect to the medical use of marijuana. In the case of a minor or an adult lacking legal capacity, the primary
caregiver shall be a parent, guardian, or person having legal custody.
Agency
Website:
http://dps.hawaii.gov/about/divisions/lawenforcement-division/ned/
MAINE
Maine Medical Use of Marijuana Act, ME. REV. STAT. ANN. tit. 13, §§ 133301 to13-3316 (West, Westlaw through 2014 Reg. Sess.).
Under the statute, qualifying patients may grow and cultivate medical
marijuana. To be a qualifying patient one must have been diagnosed with a
debilitating medical condition and have a valid written certification pertaining to the use of medical marijuana. A valid written certification is a document signed by a medical provider stating the patient is likely to gain a
therapeutic benefit from using medical marijuana.
Possession: 2 ½ ounces
Homegrown: Six marijuana plants (up to three may be mature).
Dispensaries: Yes
Illnesses: Epilepsy and other conditions characterized by seizures,
glaucoma, multiple sclerosis and other muscle spasticity disorders, nausea,
HIV/AIDS, cancer, hepatitis C, Lou Gehrig’s disease, Crohn’s disease,
Alzheimer’s disease, nail-patella syndrome, cachexia, and other conditions
subject to state approval.
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Caregivers: Must be at least twenty-one years old and have never
been convicted of a drug offense.
Agency Website: http://www.maine.gov/dhhs/dlrs/mmm/index.shtml
MARYLAND
Natalie M. Laprade Medical Marijuana Commission, MD. CODE ANN.,
HEALTH §§ 13-3301 to 13-3316 (West, Westlaw through 2014 Reg.
Sess.).
Under the statute a qualifying patient, may possess medical marijuana.
To be a qualifying patient one must obtain written certification from a treating physician that the potential benefits of the medical use of marijuana
would likely outweigh the health risks for the patient.
Possession: An amount constituting a thirty-day supply. The Commission will determine the amount.
Homegrown: No
Dispensaries: Yes
Illnesses: Chronic or debilitating disease or medical condition that results in a patient being admitted into hospice or receiving palliative care, a
chronic or debilitating disease or medical condition or the treatment of a
chronic or debilitating disease or medical condition that produces: cachexia,
anorexia, wasting syndrome, severe pain, severe nausea, seizures, severe or
persistent muscle spasms, and severe conditions or The Commission may
approve applications that include any other condition that is severe and for
which other medical treatments have been ineffective if the symptoms reasonably can be expected to be relieved by the medical use of marijuana.
Caregivers: A person who has agreed to assist with a qualifying patient’s medical use of marijuana. If the qualifying patient is under eighteen
years old the caregiver must be a parent or legal guardian.
Agency Website:
http://dhmh.maryland.gov/SitePages/Medical%20Marijuana%20Com
mission.aspx
MASSACHUSETTS
Humanitarian Medical Use of Marijuana, MASS. GEN. LAWS ch. 94C, §§ 11 to 1-14 (West, Westlaw through chs. 1 to 505 of the 2014 2d Ann.
Sess.).
Protection is provided for health care professionals, qualifying patients, personal care givers, and dispensary agents, for the medical use of
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marijuana, who comply with the specification stated in the law. The law
shall be administered by the Department of Public Health of the Commonwealth of Massachusetts. Registration cards are issued to qualifying patients
and caregivers via the Department. A qualifying patient is “a person who
has been diagnosed by a licensed physician as having a debilitating medical
condition.” MASS. GEN. LAWS ch. 94C, § 1-2(K).
Possession: Sixty-day supply is equal to ten ounces. A certifying physician may alter this amount by presenting documentation supporting the
additional need. 105 MASS. CODE REGS. § 725.004 (2013).
Home Grown: Permitted upon obtaining a hardship cultivation registration. Cultivation is limited to the location specified in the application,
registration is valid for one year, and the number of plants is limited to that
sufficient to maintain a sixty-day supply solely for the patient’s use. 105
MASS. CODE REGS. § 725.035 (2013).
Dispensaries: Yes
Illnesses: When debilitating the following conditions are included:
cancer, glaucoma, HIV positive, AIDS, hepatitis C, ALS, Crohn’s disease,
Parkinson’s disease, and MS. Also covered are “other debilitating conditions as determined in writing by a qualifying patient’s certifying physician.” 105 MASS. CODE REGS. § 725.004 (2013).
Caregivers: Must be twenty-one years of age or older. A qualifying
patient may designate up to two caregivers. Generally, a caregiver may only
provide care to one individual. Caregivers must attest s/he will not divert
marijuana elsewhere and acknowledge that the rights of the caregiver are
only applicable within the state of Massachusetts. MASS. GEN. LAWS ch.
94C, § 1-2(K); 105 MASS. CODE REGS. § 725.020 (2013).
Agency Website:
http://www.mass.gov/eohhs/gov/departments/dph/programs/hcq/medic
al-marijuana/
MICHIGAN
Michigan Medical Marihuana Act, MICH. COMP. LAWS ANN. §§
333.26421–333.26430 (West, Westlaw through P.A. 2014, No. 572 of
the 2014 Reg. Sess. of the Ninety-Seventh Leg.).
Qualifying patients, caregivers, and physicians are protected from arrest, prosecution, penalty, or denial of rights or actions by professional disciplinary boards for the medical use of marihuana in accordance with this
Act. The Act is administered by the Department of Licensing and Regulatory Affairs. Registry identification cards are issued to qualifying patients and
registered caregivers by the department. MICH. COMP. LAWS ANN. §
333.26423.
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Possession: 2 ½ ounces of useable marihuana. If held by a caregiver
then 2 ½ ounces per qualifying patient to whom s/he is connected by proper
registration. MICH. COMP. LAWS ANN. § 333.26424(a), (b)(1).
Home Grown: Twelve plants. They must be kept in an “enclosed,
locked facility.” MICH. COMP. LAWS ANN. § 333.26424(a), (b)(2).
Dispensaries: No
Illnesses: One or more of the following: cancer, glaucoma, HIV positive, AIDS, hepatitis C, ALS, Crohn’s disease, agitation of Alzheimer’s
disease, nail-patella. A chronic debilitating disease or condition that results
in: cachexia (wasting syndrome), severe and chronic pain, severe nausea,
seizures, severe and chronic muscle spasms. And other medical conditions
as approved by the department. MICH. COMP. LAWS ANN. § 333.26423(b).
Caregivers: Caregivers must be twenty-one years of age or older,
have no felony convictions within the past ten years, have never been convicted of a felony involving illegal drugs or an assaultive crime as defined
in the code of criminal procedure, and must have agreed to assist with the
patient’s use of medical marihuana. MICH. COMP. LAWS ANN. §
333.26423(b); MICH. ADMIN. CODE r. 333.101(15).
Agency
Website:
http://www.michigan.gov/lara/0,4601,7-15435299_63294_63303_51869---,00.html
MINNESOTA
Therapeutic Research Act; Medical Cannabis, MINN. STAT. ANN. §§
152.21–152.37 (West, Westlaw through the 2015 Reg. Sess. through
ch. 2).
The provision of medical cannabis to qualifying patients begins July 1,
2015. The process is under the control of the Commissioner of Health.
Qualifying patients apply to the commissioner to be enrolled in the registry
program and in doing so agree to continue treatment for the qualifying condition, report any changes in the condition, and to obtain medical cannabis
only from a registered manufacturer. The law expressly prohibits the smoking of marijuana. MINN. STAT. ANN. §§ 152.22, 152.25, 152.30.
Possession: Thirty-day supply. 39 MINN. REG. 818 (Dec. 15, 2014).
Home Grown: No
Dispensaries: Yes. MINN. STAT. ANN. § 152.29.
Illnesses: Cancer or a terminal illness with a less than one-year life
expectancy, if the condition or treatment results in one or more of the following: severe or chronic pain, nausea or severe vomiting or severe wasting, glaucoma, HIV or AIDS, Tourette’s syndrome, ALS, seizures, severe
and persistent muscle spasms, Crohn’s disease, and any other medical condition approved by the commissioner. MINN. STAT. ANN. § 152.22.
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Caregivers: Must be at least twenty-one years of age and not have any
convictions for disqualifying felonies. Registered, designated caregivers are
approved by the commission to assist patients who have been identified by
health care professionals to be unable to self-administer or acquire cannabis. MINN. STAT. ANN. § 152.22.
Agency Website: http://www.health.state.mn.us/topics/cannabis/
MONTANA
Montana Marijuana Act, MONT. CODE ANN. §§ 50-46-301 to -344 (West,
Westlaw through the 2013 Sess., and the 2014 Gen. Election).
Provides legal protections for persons covered by the Act who use marijuana to alleviate symptoms associated with a debilitating condition. Also
provides protection for those who cultivate, manufacture, deliver, and possess marijuana within the parameters of the Act as well as individuals who
assist in some of these activities. The Act establishes reporting requirements and permits local governments to establish standards for the protection of those within their jurisdiction. The Act is administered by the Department of Health and Human Services, which issues registration cards to
patients, providers and marijuana infused product providers (MIPPs). The
Department also provides for a “Landlord Permission Form,” which permits
cultivation on rented property when properly obtained and approved.
MONT. CODE ANN. §§ 50-46-301 to 50-46-302; MONT. ADMIN. R.
37.107.110 (2011).
Possession: Registered cardholders may possess twelve seedlings, a
seedling being a plant less than twelve-inches tall, four mature plants and
one
ounce
of
useable
marijuana.
http://dphhs.mt.gov/qad/Licensure/MMP/mmpfaq#159672069-how-manyplants-can-i-have-if-im-on-the-montana-marijuana-registry (last visited
Feb. 28, 2015).
Home Grown: Registered cardholders may possess twelve seedlings,
a seedling being a plant less than twelve-inches tall, and four mature plants.
Id.
Dispensaries: No
Illnesses: Cancer, glaucoma, HIV positive, AIDS, when the condition
or disease results in debilitating symptoms; wasting syndrome, severe
chronic pain that interferes with daily activities (must be documented by
physician), Crohn’s disease, MS, peripheral neuropathy, chronic painful
muscle spasms, seizure disorders, hard to control nausea, conditions leading
to hospice care, and other conditions as approved by the legislature.
Providers and MIPPs: Must be a Montana resident who is eighteen
years of age or older; must not be in the custody of or under the supervision
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of the Department of Corrections or a youth court; must not have a felony
conviction for a drug offense; must not have fraudulently represented self
as a registered cardholder or MIPP under this Act; must not have failed to
pay taxes or a judgment to a government agency; must not have defaulted
on student loans or have failed to pay child support; must not have failed to
remedy outstanding child support or tax judgments; must reapply annually.
A provider or MIPP may assist up to three registered cardholders. If the
provider or MIPP is also a registered cardholder then s/he may assist only
two additional registered cardholders. MONT. CODE ANN. § 50-46-308;
MONT.
ADMIN.
R.
37.107.115
(2011);
http://dphhs.mt.gov/qad/Licensure/MMP/mmpfaq (last visited Feb. 28,
2015).
NEVADA
Medical Use of Marijuana, 453A NE. REV. STAT. ANN. §§ 453A.010–
453A.810 (West, Westlaw through the end of the Twenty-Eighth Spec.
Sess. (2014)).
Persons in possession of a valid registry identification card are protected from prosecution for possession, delivery, or production of marijuana
as well as possession and delivery of related paraphernalia. Additionally,
protection from prosecution is provided for aiding and abetting in the possession or delivery of marijuana or related paraphernalia in connection with
a qualifying person. Registration cards are administered by the Division of
Public and Behavioral Health of the Department of Health and Human Services. NEV. REV. STAT. ANN. §§ 453A.200, .210.
Possession: 2 ½ ounces in any fourteen-day period; twelve marijuana
plants regardless of maturity and the regulatory permissible amount of edible marijuana products. NEV. REV. STAT. ANN. § 453A.200.
Home Grown: No
Dispensaries: Yes. NEV. REV. STAT. ANN. § 453A.115.
Illnesses: AIDS, cancer, and glaucoma. A medical condition or treatment therefore, that for a specific patient, results in: cachexia, persistent
muscle spasms, seizures, severe nausea, or severe pain. Any other condition
the Division deems chronic or debilitating and a condition approved pursuant to petition. NEV. REV. STAT. ANN. § 453A.050.
Caregivers: Must be eighteen years of age or older and have significant responsibility for the well-being of the person with the qualifying condition. There may be only one designated primary caregiver per person with
a qualifying medical condition.
Agency Website: http://www.health.nv.gov/MedicalMarijuana.htm
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NEW HAMPSHIRE
Use of Cannabis for Therapeutic Purposes, N.H. REV. STAT. ANN. §§ 126X:1 to -X:11 (Lexis through the 2014 Sess.).
The provisions of this law are administered by the Department of
Health and Human Services. Protection is provided to qualifying patients
for the possession and use of cannabis for therapeutic use in compliance
with the law. Additionally, caregivers possessing an acceptable amount of
therapeutic cannabis, as stated in the statute, for a qualifying patient are
protected from prosecution. Valid registry cards from other jurisdictions
will be honored within the state. Protections are also provided for providers
of therapeutic cannabis and alternative treatment centers acting in accordance with the law. Qualifying patients who have custody or visitation rights
will not be presumed to be neglectful or endangering the child(ren) when
acting in accordance with the law. Additionally, custody or visitation cannot be denied solely based on conduct in connection to the law. N.H. REV.
STAT. ANN. §§ 126-X:1, 126-X:2.
Possession: Two ounces of useable cannabis or any amount of unusable cannabis. Caregivers may possess two ounces per qualifying patient for
which s/he is a designated caregiver. N.H. REV. STAT. ANN. §§ 126-X:2 (I),
(II).
Homegrown: No. N.H. CODE R. Dep’t of Health and Human Services
He-C 401.02(m).
Dispensaries: No
Illnesses: Cancer, glaucoma, HIV positive, AIDS, hepatitis C when
antiviral treatment is being done, ALS, muscular dystrophy, Crohn’s disease, agitation associated with Alzheimer’s, MS, chronic pancreatitis, spinal
cord injuries or diseases, traumatic brain injury, injur(ies) that significantly
interfere with daily activity (must be documented by patient’s provider),
severely debilitating or terminal illness resulting in one or more of the following: elevated intraocular pressure, cachexia, anorexia as a result of
chemotherapy, wasting syndrome, constant or severe nausea, moderate to
severe vomiting, seizure, severe muscle spasms, and severe pain not responding to other treatments or where treatments have serious side effects.
N.H. REV. STAT. ANN. § 126-X:1(IX); N.H. CODE R. Dep’t of Health and
Human Services He-C 401.02(j).
Caregivers: Must be twenty-one years of age or older. Has agreed to
assist a qualifying patient with the use of therapeutic cannabis. Cannot assist more than five qualifying patients. Must have never been convicted of a
felony or any felony drug-related offense. Must obtain a valid registry card
under this law. N.H. REV. STAT. ANN. § 126-X:1(VI).
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Agency Website: http://www.dhhs.state.nh.us/oos/tcp/
NEW JERSEY
New Jersey Compassionate Use Medical Marijuana Act, N.J. STAT. ANN.
§§ 24:6I-1 to -16 (Lexis through the 216th Ann. Sess., L. 2015, c.
3NJ).
The purpose of the Act is to “protect from arrest, prosecution, property
forfeiture, and criminal and other penalties” qualifying patients use of medical marijuana. N.J. STAT. ANN. § 24:6I-2(e). The Act is administered by
the Department of Health and covers the medical marijuana activities of
qualifying patients who must be provided a certification by a physician with
whom s/he has a bona-fide physician-patient relationship. The Department
of Health issues registry identification cards to qualifying patients. N.J.
STAT. ANN. § 24:6I-2.
Possession: Two ounces per thirty-day period. N.J. STAT. ANN. §
24:6I-10.
Homegrown: No
Dispensaries: Alternative Treatment Centers provide medical marijuana based on a physician’s instructions. N.J. STAT. ANN. § 24:6I-10.
Illnesses: ALS; MS; terminal cancer; muscular dystrophy; inflammatory bowel disease including: Crohn’s disease; terminal illness with a prognosis of less than twelve months to live; one of the following if resistant to
existing conventional treatment: seizure disorders, intractable skeletal muscular spasticity, or glaucoma; one of the following when severe or chronic
pain, or sever nausea or vomiting or wasting syndrome result: HIV positive,
AIDS or cancer; any other condition approved by the Department of Health.
N.J. STAT. ANN. § 24:6I-3; N.J. ADMIN. CODE § 8:64-1.2 (2015).
Caregivers: A resident of the state who is eighteen years of age or
older, has agreed to assist a qualifying patient with the use of medical marijuana who is neither a primary caregiver to another qualifying patient, nor
the patient’s physician, has never been convicted of sale of a controlled
dangerous substance unless the conviction was at the federal level and pertained to lawful behavior under this Act, has properly registered and passed
the criminal background check and has been designated as primary caregiver on the qualifying patient’s application. N.J. STAT. ANN. § 24:6I-3; N.J.
ADMIN. CODE § 8:64-2.3 (2015).
Agency Website: http://www.state.nj.us/health/medicalmarijuana/
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NEW MEXICO
Lynn and Erin Compassionate Use Act, N.M. STAT. ANN. §§ 26-2B-1 to -7
(Lexis through the end of the Second Reg. Sess. of the Fifty-First
Leg.).
The law was enacted to permit the use of medical cannabis to alleviate
symptoms of debilitating medical conditions and treatments in a controlled
fashion. The Department of Health administers the law. Practitioners, persons licensed to prescribe and administer drugs identified in the Controlled
Substances Act, determine a patient’s status as a qualified patient. Written
certifications are not valid for more than one year. Medical cannabis must
be obtained only from in-state sources. Qualified patients must provide their
name, address, and birthdate as well as the name, address, and phone number of their practitioner. N.M. STAT. ANN. §§ 26-2B-2, 26-2B-7; N.M.
CODE R. § 7.34.2.7 (2015).
Possession: An adequate three-month supply. An adequate supply
cannot exceed six ounces of useable cannabis. If a personal production license is held, four mature plants and twelve seedlings are permitted. If
treatment is topical, a three-month supply is allowed. Additional amounts
may be permitted at the Department’s discretion. N.M. CODE R. § 7.34.2.7.
Homegrown: Permitted after obtaining a personal production license.
License may also be issued to a primary caregiver. N.M. CODE R. §
7.34.2.7(AA).
Dispensaries: Yes
Illnesses: Cancer, glaucoma, MS, spinal cord damage with objective
neurological indication of intractable spasticity, epilepsy, HIV positive,
AIDS, hospice care in accordance with rules of department, and any other
medical condition, treatment, or disease as approved by the department.
N.M. STAT. ANN. § 26-2B-3(B).
Caregivers: Must be a resident of New Mexico who is at least eighteen years of age, and have been deemed necessary to take care of the patient’s well-being, by the patient’s practitioner, with respect to the medical
use of cannabis. N.M. STAT. ANN. § 26-2B-3(F).
Agency Website: http://nmhealth.org/about/mcp/svcs/
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NEW YORK
Compassionate Care Act, N.Y. PUB. HEALTH §§ 3360–3369-e (Lexis
through 2014 released chs. 1-478).
Possession, use, acquisition, delivery, transportation, and transfer of
medical marihuana are lawful under this Act when done by a certified patient or designated caregiver holding a valid registry identification card and
in accordance with the law. To be certified, patient must be working with a
practitioner registered to issue certificates by the commissioner, must have
a serious condition documented in medical records, the registered practitioner must be qualified to treat patient’s condition, the patient must be under the continuing care of the practitioner, and the practitioner’s view is that
in looking at past treatments the patient will benefit from the use of medical
marihuana. N.Y. PUB. HEALTH §§ 3360(1), 3662.
Possession: A thirty-day supply of the dosage determined by patient’s
practitioner and that dosage is consistent with regulations by the commissioner. Product must be kept in its original packaging except for that portion being used immediately. N.Y. PUB. HEALTH § 3362.
Homegrown: No
Dispensaries: Yes. N.Y. PUB. HEALTH § 3364.
Illness: Cancer, HIV positive, AIDS, ALS, Parkinson’s disease, MS,
spinal cord damage with objective neurological indication of intractable
spasticity, epilepsy, inflammatory bowel disease, neuropathies, Huntington’s disease, and others as added by the commission. Also covered are the
following when clinically associated with or a complication of a condition
in this section: wasting syndrome or cachexia, severe or chronic pain, sever
nausea, seizures, severe or persistent muscle spasms, and other conditions
added by the commissioner. Within eighteen months of the effective date of
the Act, July 3, 2014, the commissioner will make a determination on the
following: Alzheimer’s, muscular dystrophy, dystonia, PTSD, and rheumatoid arthritis. N.Y. PUB. HEALTH § 3360(7).
Caregivers: Must be designated by the patient. Additional requirements are likely forthcoming but the regulations related to this Act have not
yet been enacted.
Agency Website:
https://www.health.ny.gov/regulations/medical_marijuana/

478

NORTHERN ILLINOIS UNIVERSITY LAW REVIEW

[Vol.

35

OREGON
Oregon Medical Marijuana Act, OR. REV. STAT. ANN. §§ 475.300–475.346
(Lexis through the 2014 Sess.).
Provides protection from civil and criminal penalties for patients using
medical marijuana on the advice of a doctor and in conformity with stated
restrictions in the Act. The Oregon Health Authority oversees the Act. The
authority will issue registry identification cards to qualified patients and/or
designated primary caregivers.
Possession: Patient or designated primary caregiver may possess
twenty-four ounces of useable marijuana, up to six mature plants, and up to
eighteen seedlings. A one-ounce limitation is placed on patients having
been convicted of certain Schedule I or II controlled substance offenses.
Growers may possess the same amounts per patient for whom s/he is a
grower. A grower may produce for no more than four qualified patients.
OR. ADMIN. R. 333-008-0080 (2015).
Homegrown: Yes
Dispensaries: Yes. OR. REV. STAT. ANN. § 475.314; OR. ADMIN. R.
333-008-1000-, 333-008-1400 (2015).
Illnesses: Cancer, glaucoma, agitation related to Alzheimer’s disease,
HIV positive, AIDS, or side-effects related to the treatment of the afore
mentioned conditions. Medical treatments or conditions resulting in cachexia, severe pain, severe nausea, seizures, including those caused by epilepsy,
persistent muscle spasms, including those caused by MS, PTSD, or any
other condition or side-effect approved by the Authority. OR. REV. STAT.
ANN. § 475.302(3).
Caregivers: Designated primary caregivers must be eighteen years of
age or older, have the significant responsibility for managing the well-being
of a person with a debilitating medical condition, be designated as such on
the patient’s registry identification application card, and may not be the
patient’s physician. OR. REV. STAT. ANN. § 475.302(5).
Agency Website:
https://public.health.oregon.gov/DiseasesConditions/ChronicDisease/
MedicalMarijuanaProgram/Pages/index.aspx
RHODE ISLAND
The Edward O. Hawkins and Thomas C. Slater Medical Marijuana Act, R.I.
GEN. LAWS ANN. §§ 21-28.6-1 to -14 (Lexis through Jan. 2014 Sess.).
The purpose of the Act is to protect from arrest and prosecution, other
criminal penalties and property forfeiture, patients with debilitating medical
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conditions, their caregivers, and physicians. Protection is also provided for
a patient cardholder who grows and sells or distributes marijuana as identified in the Act to a compassion center cardholder. The Act is administered
by the Rhode Island Department of Health.
Possession: 2 ½ ounces of useable marijuana and up to twelve mature
plants. Plants must be stored indoors. Additionally, up to twelve seedlings
may be possessed. R.I. GEN. LAWS ANN. §§ 21-28.6-4(a), (d), and (e).
Homegrown: Permitted. R.I. GEN. LAWS ANN. § 21-28.6-4(a) (possession includes mature and immature plants).
Dispensaries: Yes, as Compassion Centers. R.I. GEN. LAWS ANN. §
21-28.6-3(2)(i); 14-035 R.I. CODE R. § 1.2.
Illnesses: Cancer; glaucoma; HIV positive; AIDS; hepatitis C and
treatments thereof. Chronic debilitating diseases, medical conditions or
treatments thereof that result in: cachexia; severe debilitating, chronic pain;
severe nausea; seizures, including but not limited to those associated with
epilepsy; sever or persistent muscle spasms, including but not limited to
those associated with MS or Crohn’s disease; agitation of Alzheimer’s disease; or any other condition or treatment approved by the department. R.I.
GEN. LAWS ANN. § 21-28.6-3(3).
Caregivers: A natural person must be twenty-one years old or older
and may assist no more than five qualifying patients at once. Caregivers
may also be compassion centers registered under R.I. GEN. LAWS ANN. §
21-28.6-12 who have been designated as a primary caregiver by a qualified
patient. R.I. GEN. LAWS ANN. §§ 21-28.6-3(2)(i), (9); 14-035 R.I. CODE R.
§§ 1.2, 1.12.
Agency Website:
http://www.health.ri.gov/healthcare/medicalmarijuana/
VERMONT
Therapeutic Use of Cannabis, VT. STAT. ANN. tit. 18, §§ 4471–4474m
(Lexis through the 2013 adjourned Sess.).
Provides protection from arrest or prosecution for registered patients
and their registered caregivers, health care professionals who have participated in the patient’s application process. To qualify as a registered patient,
one must be diagnosed with a debilitating disease or condition by a physician with whom the patient has a bona-fide healthcare professional-patient
relationship. The Act is administered by the Department of Public Safety.
Possession: Two ounces of useable marijuana, up to two mature marijuana plants, and seven immature plants may be possessed collectively by
the patient and caregiver. VT. STAT. ANN. tit. 18, § 4472(10).
Homegrown: Permitted.
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Dispensaries: Yes. VT. STAT. ANN. tit. 18, §§ 4474e–4474i.
Illnesses: Cancer, MS, HIV positive, AIDS or the treatment of the
aforementioned conditions if the disease or treatment thereof results in severe, persistent, and intractable symptoms; chronic or debilitating diseases
resulting in cachexia, severe pain, severe nausea, or seizures. VT. STAT.
ANN. tit. 18, § 4472(4); 28-003 VT. CODE R. § 3.
Caregivers: Must be twenty-one years of age or older, never been
convicted of a drug related crime, been issued a registration card by the
Department of Public Safety, and has agreed to be responsible for the medical marijuana use related well-being of a registered patient. VT. STAT. ANN.
tit. 18, § 4472(11); 28-003 VT. CODE R. § 1.12.
Agency Website: http://vcic.vermont.gov/marijuana_registry
WASHINGTON
Medical Cannabis, WASH. REV. CODE ANN. §§ 69.51A.005–69.51A.903
(Lexis through the 2014 Reg. Sess. and the 2014 Gen. Election).
Provides protection from arrest, prosecution, or other state criminal or
civil consequences when lawfully using medical marijuana in compliance
with the law. Also protected are designated providers and health care professionals working within the parameters of the medical marijuana laws.
Qualifying patients must be residents of the state of Washington at the time
of the diagnosis of their terminal or debilitating medical condition.
Possession: No more than fifteen cannabis plants; twenty-four ounces
of useable cannabis; cannabis product only in an amount that could be made
with twenty-four ounces of cannabis, or a combination of useable cannabis
and cannabis product. A person who is both a qualifying patient and a designated provider may possess two times the aforementioned amounts.
WASH. REV. CODE ANN. § 69.51A.040.
Homegrown: Yes. WASH. REV. CODE ANN. § 69.51A.040.
Dispensaries: Yes. WASH. ADMIN CODE §§ 314-55-005 through 31455-540 (2015).
Illnesses: Cancer, HIV, MS, epilepsy or other seizure disorder, spasticity disorders, intractable pain (pain that is not relieved by standard treatments), glaucoma (pain form which is not relieved by standard treatments),
Crohn’s disease (debilitating symptoms of which are not relieved by standard treatments), hepatitis C (where debilitating nausea or intractable pain
are not relieved by standard treatment), diseases, where symptoms are not
relieved by standard treatment, including nausea from anorexia, vomiting,
wasting, appetite loss, cramping, seizures, muscle spasms or spasticity, and
any other medical condition approved by the Washington State Medical
Quality Assurance Commission. WASH. REV. CODE ANN. § 69.51A.010(4).
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Caregivers: Is eighteen years of age or older, designated in writing
by the patient to be the designated provider, is prohibited from consuming
the medical marijuana that is intended for medical use by the patient, and
may be a designated provider for only one patient. WASH. REV. CODE ANN.
§ 69.51A.010(1).
Agency Website:
http://www.doh.wa.gov/YouandYourFamily/Marijuana/MedicalMariju
anaCannabis

THE UNITED STATES SUPREME COURT AND MEDICAL MARIJUANA USE
UNDER THE CONTROLLED SUBSTANCES ACT
Gonzales v. Raich, 545 U.S. 1 (2004).
The United States Supreme Court in Gonzales v. Raich determined
that the Comprehensive Drug Abuse Prevention and Control Act of 1970
(commonly referred to as the Controlled Substances Act) had constitutional
supremacy over state laws allowing medical marijuana use. Thus, individuals using medical marijuana were not protected from federal prosecutions.
The case arose out of California. The respondents in the case were California residents suffering from serious medical conditions. In order to alleviate
symptoms associated with these conditions they were using medical marijuana under the California Compassionate Use Act. Gonzales, 545 U.S. at
6. Respondent Monson cultivated her own marijuana and Respondent Raich
was provided with medical marijuana by two registered caregivers. Id. at 7.
In August 2002, federal agents seized and destroyed the marijuana plants in
Monson’s home. Id. at 8. Raich’s home was never entered by federal
agents, however she feared this could happen at any time. Raich v. Ashcroft,
248 F. Supp. 2d 921 (N.D. Cal. 2003). The United States Supreme Court
stated the issue as follows: “whether Congress’ power to regulate interstate
markets for medicinal substances encompasses the portions of those markets that are supplied with drugs produced and consumed locally.” Gonzales, 545 U.S. at 9. While the Court acknowledged the “troubling facts” of
the case at hand, it found that the Controlled Substances Act was a “valid
exercise of federal power.” Id. at 9.

RECENT CONGRESSIONAL ACTIONS
The U.S. House and Senate both recently introduced bills that would
end the long-standing conflict between state and federal laws with respect
to medical marijuana. The Regulate Marijuana Like Alcohol Act, H.R.
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1013, 114th Cong. (2015), introduced in the United States House of Representatives on February 20, 2015, and The Compassionate Access, Research
Expansion and Respect States Act, S. 683, 114th Cong. (2015), introduced
in the United States Senate on March, 10, 2015, would reschedule marijuana from Schedule I classification to Schedule II under the Controlled Substances Act, thus recognizing it for medical use.

ARTICLES
The following materials represent a select group of articles addressing
medical marijuana in different areas including employment, federalism,
family law, and transportation. Also included in this section is a summary
of the Department of Justice’s memorandums addressing federal enforcement issues. Intermixed are additional statutory and case law summaries
when connected to the article topics.
FEDERALISM AND MEDICAL MARIJUANA
Gerald Caplan, Medical Marijuana: A Study of Unintended Consequences,
43 MCGEORGE L. REV. 127 (2012).
This Article highlights the evolution of medical marijuana laws in
Colorado, California, and Michigan. Noted is that the initial applications for
use in these states were on the low end with numbers increasing dramatically after the 2009 statement from the Obama administration. The statement
was interpreted as stating individuals in compliance with state law would
not be arrested under federal law. For example, in Colorado, from January
2009 to January 2010, there was an 871% increase in registrants for medical marijuana use under the state law. Also noted is the lack of consistency
in some jurisdictions with respect to certain aspects of the laws. In California, the amount of medical marijuana that a person may possess varies by
county. State law says up to eight ounces may be possessed; yet a significantly higher amount is allowed in some counties. In Michigan, as in other
states, the author notes that a small number of physicians certify a significant number of patients for medical marijuana use. Mr. Caplan stated that
the original thought with respect to medical marijuana was that a small
number of older adults with debilitating conditions would use medical marijuana. Very few patients would be under the age of forty, and marijuana use
would not be permitted for conditions that were hard to verify such as stress
and anxiety. The author however indicates that this has not been the practice in many jurisdictions, and in some areas, physicians are in practice only
to see patients wanting to qualify for medical marijuana use. He indicates
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how this practice is very different from the usual doctor-patient relationship. The author also discussed the increased number of dispensaries and
how many are very involved in marketing their businesses. Mr. Caplan ends
with a discussion of law enforcement issues related to the new medical marijuana programs and the broader effects of additional states legalizing the
recreational use of marijuana.
Erwin Chemerinsky et al., Cooperative Federalism and Marijuana Regulations, 62 UCLA L. REV. 74 (2015).
The authors propose a solution to the federalism issue with respect to
the Controlled Substances Act and marijuana. The proposed solution involves permitting states wishing to legalize marijuana an opportunity to
opt-out of Controlled Substances Act provisions related to marijuana as
long as the states meet specified criteria. The history of marijuana is covered starting with some states criminalizing the drug in the 1910s through
the recent Department of Justice’s response to Colorado and Washington
legalizing the recreational use of marijuana. The authors then proceed to
address the problems that the federal criminalization of the drug poses to
businesses and those seeking to use marijuana legally. Topics covered include the need for a marijuana business to be cash only due to banking laws
that threaten prosecution for money laundering. Also covered is the problem with federal taxes and the exorbitant amounts that must be paid by “illegal” entities. A provision of the Internal Revenue Code requires an entity
operating in violation of federal drug laws to pay a tax that creates a significant disadvantage to the entity–e.g., not being able to deduct business expenses from income. A third challenge covered is the availability of lawyers
able and willing to provide services. Fourth, the authors look at the consequences of those using legalized marijuana, in an employment situation,
individuals on parole and with a probation status, and in family law situations. The next area analyzed is the federal preemption law with respect to
the Controlled Substances Act and the anti-commandeering doctrine of the
Tenth Amendment. Section 903 of the Controlled Substances Act is discussed in that the authors indicate it shows Congress’s intent not to completely preempt the regulation of controlled substances in the Controlled
Substances Act. Lastly, the authors discuss crafting federal laws to work
with state marijuana laws by employing cooperative federalism.
Todd Grabarsky, Conflicting Federal and State Medical Marijuana Policies: A Threat to Cooperative Federalism, 116 W. VA. L. REV. 1 (2013).
The author intends to explain the zone in which marijuana related activities can be both legal and illegal. In doing so he states that the enforcement of federal drug laws in an unpredictable manner can threaten the ef-
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fectiveness and cooperative efforts of federal and state authorities in enforcing “dual-ban” drug laws. Mr. Grabarsky summarizes the Department of
Justice memorandums and the changing landscape in legalized marijuana
with two states recently voting to legalize its recreational use. His main
focus though is on the conflict between federal law and California’s Compassionate Use Act. The author summarizes the California law and the state
case law that evolved in relation to the Act. He then discusses the Controlled Substances Act and Congress’s and the Drug Enforcement Agency’s
inaction in rescheduling marijuana. In a section on de jure constitutional
authority, the author discusses commandeering, preemption, and conditional spending. He also addresses the obstacles to the federal enforcement of
marijuana violations. The author next discusses the change in federal enforcement and the crackdown on medical marijuana entities profiting from
the sale of medical marijuana whereby distributors in California were
closed and dispensaries received cease and desist letters. The author discusses how these activities threatened cooperative federalism and also addresses the idea with respect to those states authorizing recreational use of
marijuana. The author next discusses the idea of creating an exemption for
persons and entities complying with state laws and the viability of such a
system.
Troy E. Grandel, One Toke Over the Line: The Proliferation of State Medical Marijuana Laws, 9 U. N.H. L. REV. 135 (2010-2011).
Mr. Grandel approaches his article acknowledging that he is making
the assumption that there are valid medicinal qualities associated with marijuana. He provides a discussion of the changing view toward marijuana in
the 1930s from a medicinal product to one associated with drug use and
deviance. He then summarizes the start of the “war on drugs” in the 1970s
and the Comprehensive Drug Abuse Prevention and Control Act. A brief
look is taken at the 1980s action creating a drug czar. The author then begins a look at California in the 1990s and other states, in subsequent years,
enacting medical marijuana laws. Mr. Grandel summarizes the votes in
each state legalizing medical marijuana. He also identifies the condition/diseases for which medical marijuana can be used. Other issues addressed are the problem employees may face in the workplace when properly using medical marijuana and the fact that marijuana is an agricultural
crop having a stand-alone value.
Robert A. Mikos, Preemption Under the Controlled Substances Act, 16 J.
HEALTH CARE L. & POL’Y 5 (2013).
The author identifies the significant confusion and various interpretations of courts relating to states’ adoptions of the legalization of medical,
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and in some instances recreational, marijuana use. He notes that states have
differed on issues such as the ability to license marijuana distributors noting
that even courts within a single state have reached different conclusions on
this issue. In this Article, Mr. Mikos proposes a direct conflict test where
“state law is preempted only if it requires someone to violate federal law.”
He provides a general discussion of preemption, including field preemption,
direct conflicts, and obstacle conflicts. Additionally, preemption with respect to the Controlled Substances Act is addressed and the language of
section 903 is evaluated and its application in cases where the courts interpreted it to mean the Controlled Substances Act preempted all state law
conflicts. In discussing the reasons the obstacle conflict preemption rule is
too broad, the author covers differences between legalization and regulation
and why that distinction is important in the medical marijuana discussion.
Another factor presented by the author is the concept that Congress intended to preempt the creation of regulations that promote rather than restrict
marijuana activities. He uses examples such as state subsidies for medical
marijuana being preempted as such action would drive the cost down and
thus promote marijuana use, whereas licensing, taxing or requiring registration would add to the cost of marijuana, at least minimally, thus restricting
the activities. The author goes on to argue the benefits of a direct conflict
rule, starting with how such a rule would help courts avoid the commandeering trap, permit them to not preempt regulations that place restrictions
on the marijuana market, and to permit state laws that are only indirectly
affecting the actions of Congress. Mr. Mikos proceeds to analyze state laws
that may pose a direct conflict to the Controlled Substances Act and separates these laws into those legalizing marijuana related activities as well as
those that promote marijuana related activities. He indicates in his analysis
that only a few states have laws that are in direct conflict with the Controlled Substances Act.
Michael D. Ramsey, American Federalism and the Tragedy of Gonzales v.
Raich, 31 U. QUEENSLAND L.J. 203 (2012).
The author states that the decision in Gonzales v. Raich was the “U.S.
Supreme Court’s worst modern decision.” Id. at 203. In support of his
stance, he identifies four propositions: 1) the shocking implausibility of
Gonzales v. Raich; 2) Gonzales v. Raich involves “a matter . . . that is core
to the U.S. constitutional system . . . .” Id. at 203; 3) Raich came at a time
of reinvigoration of federalism and offered the opportunity for expansion of
judicial protection of federalism; and 4) Raich undercut the attempt to return to stronger federalism. In his essay, Mr. Ramsey provides a history of
federalism beginning with the birth of the United States. He continues with
a revival of it in the 1990s with the case of Gregory v. Ashcroft, 501 U.S.
452 (1991). The author notes his observation of a movement away from
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federalism as intended in the Constitution but prior to Raich saw a movement to “rectify the constitutional departures.” Id. at 224. The author notes
changes in the Court once again affected the federalism issue and its direction.
David S. Schwartz, Presidential Politics as a Safeguard of Federalism: The
Case of Marijuana Legalization, 62 BUFF. L. REV. 599 (2014).
Mr. Schwartz discusses the movement of the Court between the nondeferential and deferential review of federalism, noting that the nondeferential view in the Lochner era and the deferential view applied in the
1930s and early 1940s as a “substantial effects” test. Also covered is the use
of the Tenth Amendment in the federalism discussions. The author addresses the “political safeguards of federalism” theory and the idea that Congress
and the President are better situated to strike a national versus local regulatory balance. The origin of the phrase “political safeguards of federalism”
and Professor Herbert Wechsler’s article are discussed. He follows with a
discussion of weaknesses in the theory noted by Professor Larry Kramer. A
position the author notes, of Kramer, is that state autonomy is protected by
party politics. The author also references the 2013 article by Robert Mikos
discussing the “under-enforcement” of the federal law and hypothesizes
that the actual policy of the Obama administration leads to this underenforcement. Mr. Schwartz identifies marijuana regulation as “one of the
most complex regulatory problems in the history of federalism.” In discussing this problem the author covers state’s legalization of marijuana and then
addresses the Controlled Substances Act, the Supremacy Clause indicating
state laws may not supersede federal laws (preemption), and the impact of
state legalization on federal law enforcement. Additionally, he addresses
the lack of action on behalf of Congress or the Attorney General to reschedule marijuana. The author moves into a discussion of the Electoral
College and swing state votes when a group of swing states hold a political
or social idea that is different from the national policy view on the same
topic. Of the twenty states with legalized medical marijuana the author
identifies thirteen of them as potential swing states. He then proceeds to
discuss drug policies and presidential campaigns followed by an analysis of
what each branch of government can do to protect federalism in some instances.
Vijay Sekhon, Highly Uncertain Times: An Analysis of the Executive
Branch’s Decision to not Investigate or Prosecute Individuals in Compliance with State Medical Marijuana Laws, 37 HASTINGS CONST. L.Q. 553
(2009-2010).
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The author addresses the efficacy of President Obama and Attorney
General Eric Holder’s position to not enforce federal drug laws against the
legalized use of medical marijuana in light of the Separation of Powers
clause of the United States Constitution. The author states that the enforcement policy is in direct conflict with the Controlled Substances Act (CSA),
and the decision to not enforce in these instances must be drawn from prosecutorial discretion. He indicates this is supported by a memorandum from
the Deputy Attorney General of the United States Department of Justice. In
his analysis he looks at the Wayte case and identifies why the concerns regarding judicial review in that case are not the same when applied to the
decision not to enforce federal laws in medical marijuana cases. Because of
the doctrine of sovereign immunity the author cautions against being too
comfortable with safety from compliance with state laws thus resulting in
protection based on the Executive Branch’s stated enforcement policy. He
writes that an individual citizen cannot sue the government without the
government’s permission–the government has qualified immunity–thus an
individual qualified in his or her state to use medical marijuana cannot challenge the Executive Branch’s enforcement position if that individual is arrested and charged under federal drug laws. However, Congress is not prohibited from suing to remove the enforcement policy. In order to remove
the uncertainties faced by those operating under the rights given to them by
state law, the author urges Congress to pass and the President to sign legislation codifying the enforcement policy regarding the use of medical marijuana in compliance with state laws.
EMPLOYMENT ISSUES ASSOCIATED WITH MEDICAL
MARIJUANA
Francine Bailey, Reefer Madness: Lighting Up in the Dairyland, WIS.
LAW., Nov. 2014, at 24.
This Article examines whether or not Wisconsin employers may terminate employees for using recreational marijuana in states where recreational marijuana is permitted. The author argues that Wisconsin currently
does not permit the use of recreational marijuana or provide protections for
medical marijuana users; given the drug’s popularity, it is highly likely that
many Wisconsin employees are using marijuana when off duty. She notes
that Wisconsin courts have not addressed either medical marijuana or legalized recreational marijuana. However, she explores the legislation in Colorado and Washington that permit the recreational use of marijuana. She also
discusses the growth in “pot tourism” in these states. Finally, she looks at
current case law with regards to medical marijuana in the workplace, and
how a Wisconsin court might rule in an employment case involving legal
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recreational marijuana. She concludes that it is likely a court would use the
reasoning courts have adopted in the medical marijuana cases. Therefore, it
is unlikely that a Wisconsin employee would prevail in an employment case
where the employee is terminated for using legal recreational marijuana in
another state.
Jay S. Becker & Saranne E. Weimer, Legalization of Marijuana Raises
Significant Questions and Issues for Employers, N.J. LAW., Dec. 2014, at
66.
This Article examines employers’ potential obligations in states where
medical marijuana is legal. First, the Article discusses the legal conundrum
that will exist so long as the federal government continues to classify marijuana as an illegal drug. In addition, the Article looks at whether or not employers must provide medical marijuana users an accommodation under the
Americans with Disabilities Act. It concludes that under federal law there is
no requirement. However, under some state statutes, the answer is not as
simple. The Article provides case examples from around the country where
different courts have examined this issue. It also discusses the challenges of
providing an accommodation as well as issues associated with medical marijuana and workers’ compensation and health insurance.
Lori A. Bowman & Jonathan S. Longino, Taking the High Road-The
Healthcare Provider’s Duty to Accommodate Employees’ Medical Marijuana Use, 5 J. HEALTH & LIFE SCI. 34 (2012).
This Article examines the legal landscape for healthcare providers
when it comes to accommodating bona fide medical marijuana users who
also happen to be healthcare providers. Here, the authors trace the growth
of the medical marijuana industry. Then, they look at the inconsistencies
between state and federal law with regards to medical marijuana and protection from criminal prosecution. Next, they shift to the employment law
arena by looking at whether there is a duty to accommodate medical marijuana users under the Americans with Disabilities Act (ADA). They ultimately conclude that there is not, since the ADA is directly tied to the Controlled Substances Act (CSA). They turn to state laws and look at two approaches—the no accommodation approach and the no discrimination approach. The no accommodation approach refers to state medical marijuana
laws that make a specific reference in the statute that employers are not
required to accommodate medical marijuana. For this discussion they examine the California, Oregon, and Washington statutes. The no discrimination approach refers to state medical marijuana laws that provide protections to employees who are bona fide medical marijuana users. For this
discussion they examine the Rhode Island, Maine, and Arizona statutes.
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Finally, they examine the special health and safety issues that a healthcare
provider faces when it comes to medical marijuana and its employees. They
conclude with several recommendations for health care provider employers.
John Campbell, Coats v. Dish: A Chance to Clear the Legal Haze Surrounding Medical Marijuana, 91 DENV. U. L. REV. ONLINE 79 (2014).
This Article examines the history of medical marijuana in Colorado
and the current state of the law. It explains that while the medical marijuana
statute has been on the books for ten years, the Colorado Supreme Court
has not weighed in on medical marijuana’s lawfulness. It suggests that this
is likely to change in 2015, because the Court has agreed to hear an employment case (Coats v. Dish Network LLC) where it is likely to determine
whether or not medical marijuana is indeed lawful in Colorado. The rest of
the Article examines Colorado’s law, the case law associated with the law,
the facts and status of the Coats case, and how the case could be decided.
Holli L. Hartman, Legalized Marijuana and the Workplace: Preparing for
the Trend, 38 EMP. REL. L.J. 4, Spring 2013, at 72.
This Article examines the legal landscape for employers located in
states with medical marijuana statutes. Ultimately, the author recommends
taking a proactive approach by reviewing and revising employment policies
and handbooks. The author discusses the decriminalization of medical marijuana on the state level as well as the federal government's current approach
to criminal enforcement. She explores the fact that the federal approach has
largely affected the state courts’ approach to medical marijuana in the
workplace. She provides a brief analysis of current case law. Then, she
concludes with recommendations for employers. She argues for employers
to clearly state their approach to medical marijuana in employment policies
and procedures. She suggests that this may cut down on litigation because
employees will know up front where they stand with regards to their employment and the use of medical marijuana.
Stacy A. Hickox, Drug Testing of Medical Marijuana Users in the Workplace: An Inaccurate Test of Impairment, 29 HOFSTRA LAB. & EMP. L.J.
273 (2012).
This Article examines the use of urinalysis tests to take adverse employment actions against employees who are impaired in the workplace.
She argues that the reliance on this type of testing is inaccurate and unreliable when it comes to bona fide medical marijuana users. The author gives
an overview of the existing medical marijuana statutes and the fact that
most of these statutes provide language specifying that employers do not
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have an obligation to accommodate medical marijuana in the work place.
But, many of those statutes do not contemplate off-duty legal medical marijuana use. Then, she explores research discussing marijuana’s effect on
users and the fact that there is no clear guidance for when a medical marijuana user should be protected from termination based on intoxication or impairment. Next, she examines whether traditional drug tests are appropriate
for determining whether or not an employee is impaired or intoxicated in
the workplace. Finally, she offers two solutions to the problem of inaccurate results. She suggests adopting either the approach that criminal courts
take with regard to intoxication, or the approach that is used in worker’s
compensation cases. Essentially, she argues that when employers take adverse actions based on impairment, employers should look at whether or not
the employee is truly affected by marijuana while on duty, not the results of
a urinalysis test.
Matthew D. Macy, Employment Law and Medical Marijuana—An Uncertain Relationship, 41 COLO. LAW. 57 (2012).
This Article examines how medical marijuana laws have created new
issues in the employment law arena and some uncertainty for employers. It
explores the split between federal and state law. Then, it looks at how the
case law is slowly developing in states with medical marijuana statutes. The
author points out that while there is relatively little case law, the case law
that does exist seems to favor employers. He explores several different arguments that have been brought and have failed. He looks at the Americans
with Disabilities Act and then surveys related state laws in Colorado and
Oregon. Next, he explores Colorado’s anti-discrimination and lawful acts
statutes. He concludes that these statutes also will not likely protect an employee who is also a bona fide medical marijuana user. Finally, he explores
the strength of public policy arguments in wrongful discharge claims and
concludes that these arguments will also likely fail. The underlying cause of
all these arguments failing is the split between federal and state law with
regards to how marijuana is classified. He also argues that the state statutes
were intended to protect people from criminal prosecution, and the employment law ramifications were either not contemplated or legislatures did
not intend to grant that type of protection.
McGuire Woods, But I have a Prescription!–Employee Drug Tests in the
Age of Medical Marijuana, THE SOC’Y FOR HUMAN RES. MGMT. (July 1,
2010),
http://www.shrm.org/legalissues/stateandlocalresources/pages/buihaveapres
cription.aspx.
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This Article examines ADA considerations that must be made when an
employer issues discipline to its employees for using medical marijuana.
The Article points out that the ADA does not protect employees from the
“illegal use of drugs.” However, if there is an adverse employment action
associated with a qualified individual with a disability using medical marijuana, the employer must be able to show the motivating factor for the adverse action was not the employee’s disability. In addition, the Article provides a list of recommendations for employers to take to minimize their
risks for lawsuits.
Michael D. Moberly & Charitie L. Hartsig, Smoke—And Mirrors? Employers and the Arizona Medical Marijuana Act, ARIZ. ATTORNEY, July-Aug.
2011, at 30.
This Article examines the managerial and legal problems Arizona employers face in light of the state’s medical marijuana statute. First, the authors explore the state level decriminalization of medical marijuana. They
point out that nearly all the medical marijuana statutes are silent to the employment issues associated with this decriminalization. However, Arizona’s
statute provides specific language prohibiting employers from discriminating against medical marijuana users in hiring, promotion, or other terms and
conditions of employment. The authors discuss some of the potential issues
this statute creates because it fails to define “impairment.” They explore the
problem with complying with federal laws and regulations, such as the Occupational Health and Safety Administration’s regulations governing workplace safety. They argue that until Arizona’s Department of Health Services
defines “impairment” employers will be operating in an uncertain area and
should proceed with caution.
Amy Komoroski Wiwi & Nicole P. Crifo, The Unintended Impact of New
Jersey’s New Medical Marijuana Law on the Workplace, 36 EMP. REL. L.J.,
Summer 2010, at 33.
This Article examines the implications of New Jersey’s medical marijuana statute on New Jersey workplaces. The New Jersey statute is similar
to many of the other state statutes in that it decriminalizes medical marijuana use, but it is silent as to workplace implications such as drug testing and
drug use policies. However, the statute does provide that employers are not
required “to accommodate the medical use of marijuana in any workplace.”
The Article pays particular attention to employers considering accommodating medical marijuana. The authors suggest that there are three important things to consider: whether an accommodation is appropriate for the
particular workplace, whether an accommodation will trigger liability under
anti-disability discrimination laws, and whether there is an ability to verify
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registry status. Finally, the authors provide a list of recommendations for
employers who opt to accommodate medical marijuana in the workplace.
STATE STATUTES THAT PROVIDE PROTECTION TO EMPLOYEES
USING MEDICAL MARIJUANA
The following is a sampling of state statutes that provide protection to
employees using medical marijuana. The first state to pass this type of antidiscrimination statute was Rhode Island. The state’s medical marijuana
statute specifically prohibits employers from penalizing employees for being medical marijuana cardholders. Maine also prohibits employers from
discriminating against employees who are registered medical marijuana
users. Arizona and Delaware’s statutes use stronger language. The Arizona
law implies that employers will be barred from disciplining employees for
using or limiting use of off-duty medical marijuana, while the Delaware
statute states that employers may not discriminate against medical marijuana users in hiring, terminating, or in other terms or conditions of employment. Moreover, an employer may not terminate a medical marijuana user
for a positive drug test, unless the employee was using on the job.
R.I. GEN LAWS § 21-28.6-4(b) (West, Westlaw through chapter 555 of
the Jan. 2014 Sess.).
ME. REV. STAT. tit. 22, § 2423-E(3) (West, Westlaw through 2015
First Reg. Sess. of the 127th Leg.).
ARIZ. REV. STAT ANN. § 36-2813(B) (West, Westlaw through legis. effective Feb. 24, 2015 of the First Reg. Sess. of the Fifty-Second Leg.).
DEL. CODE ANN. tit. 16, § 4905A(a)(3) (West, Westlaw through 80
Laws 2015).
THE STATE COURTS WEIGH IN ON MEDICAL MARIJUANA AND
THE WORKPLACE
Coats v. Dish Network, L.L.C., 303 P.3d 147 (Colo. App. 2013), cert.
granted, No. 13SC394, 2014 WL 279960 (Colo. Jan. 27, 2014).
In this case, the court examined whether an employer is prohibited
from discharging employees for off-the-job use of medical marijuana. Here,
Coats filed suit after he was terminated for violating Dish Network’s drug
policy. Coats, a quadriplegic, was a licensed Colorado medical marijuana
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user. He used marijuana within the limits of the license and he was never
under the influence at work. However, he tested positive for marijuana and
this constituted a violation of Dish Network’s policy.
To makes its decision, the court examined Colorado’s “Lawful Activities Statute.” Under the statute, employers are prohibited from terminating
employees for engaging in lawful activities off hours. Here, the court had to
decide whether medical marijuana was considered “unlawful.” After examining the legislative history, the court ultimately concluded that the statute
did not contemplate protections for a federally prohibited off-the-job activity. Therefore, employers are not barred from enforcing drug policies with
regards to medical marijuana.
The Colorado Supreme Court has granted certiorari and will hear the
case sometime this year.
Roe v. Teletech Customer Care Mgmt., 257 P.3d 586 (Wash. 2011).
In this case, the court looked at whether or not the Washington State
Medical Use of Marijuana Act protects employees from adverse employment actions with regards to employee use of medical marijuana. Here, Roe
was a bona fide medical marijuana user, who only ingested marijuana in her
home during off-duty hours. In 2006, Roe was offered a position with Teletech contingent on the results of a drug-screening test. Roe informed the
company of her medical marijuana use and took the drug test. After taking
the test, she began her employment training. Shortly thereafter the company
received the results of the drug test, which she failed. Upon receiving the
results, Roe was terminated.
To make its decision, the court examined the state’s medical marijuana
statute. The court noted that the only reference to employment was “nothing
in this chapter requires any accommodation of any on-site medical use of
marijuana in any place of employment.” Looking at the statutory language,
on its face, the court concluded that the statute was not intended to protect
an employee from discharge because of medical marijuana use—even if the
use occurred off-duty. Employers were still entitled to use mandatory drug
tests as a condition of employment. The court also noted that Washington
patients have no legal right to use marijuana under federal law, therefore a
public policy argument fails because the activity is illegal.
Emerald Steel Fabricators v. Bureau of Labor & Indus., 230 P.3d 518
(Or. 2010).
In this case, the court examined whether under the state’s disability
statute employers had an affirmative duty to accommodate medical marijuana. Here, the employee in question began using medical marijuana in
2002. The employee complied with all the provisions in the state’s medical
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marijuana statute. In 2003, Emerald Steel Fabricators (Emerald) hired employee on a temporary basis. During this time, employee continued to ingest medical marijuana off-duty. Knowing that Emerald was considering
making the position permanent, the employee told his supervisor about his
medical marijuana use. One week later, the employee was terminated.
To make its decision, the court considered how the federal laws intersected with the state laws. Ultimately, the court concluded that there is no
duty to confer with a disabled employee about his marijuana use, because
under federal law marijuana use is illegal. Moreover, the court concluded
that the federal Controlled Substances Act preempts the state’s disability
statute.
Ross v. RagingWire Telecomm., Inc., 174 P.3d 200 (Cal. 2008).
In this case, the court considered whether under the state’s medical
marijuana statute employers are required to permit its employees to use
medical marijuana, and whether employers must accommodate medical
marijuana use. Here, Ross was a bona fide medical marijuana user. He ingested marijuana to alleviate pain from injuries he sustained during active
military duty. However, he was terminated from his new position at RagingWire Telecommunications (RagingWire) for failing a pre-employment
drug test.
To make its decision, the court considered that the state’s medical marijuana statute required RagingWire to permit Ross to continue his medical
marijuana use. First, the court determined that the state’s medical marijuana
statute only applied to criminal protections. Second, the court determined
that the statute only specifically addressed on-site accommodations, and the
statute was silent to off-sight use, therefore it did not cover off-site use and
accommodation.
THE FEDERAL COURTS WEIGH IN ON MEDICAL MARIJUANA
AND THE WORKPLACE
Casias v. Wal-Mart Stores, Inc., 695 F.3d 428 (6th Cir. 2012).
In this case, the court considered whether or not Michigan’s medical
marijuana statute prevented Michigan employers from terminating employees for testing positive for marijuana in violation of a company drug policy.
Here, Casias was a bona fide medical marijuana user. He ingested marijuana to alleviate the pain associated with his cancer. In 2009, he was injured
on the job. This injury was not associated with his marijuana use. Due to
the on-the-job injury, Casias was required to take a drug test before returning to work. He informed the testing staff that he was a registered medical
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marijuana user. Then he took the drug test and failed it. Upon receiving the
results, Wal-Mart terminated his employment.
The court ultimately decided that the statute did not prevent employers
from enforcing their drug policies. The court reasoned that the statute was
intended to protect against criminal prosecution, not adverse employment
actions.
THE DEPARTMENT OF TRANSPORTATION WEIGHS IN ON
MEDICAL MARIJUANA AND THE WORKPLACE
DOT Office of Drug and Alcohol Policy and Compliance Notice
(Oct.
22
2009),
http://www.dot.gov/sites/dot.dev/files/docs/ODAPC_medicalmarijuana
notice_0.pdf.
The Department of Transportation issued a notice informing employers that state medical marijuana laws do not supersede federal law. Therefore, employers in the trucking, railroad, airline and transit system industries must follow the federal regulations with regards to drug testing. And,
if an employee who uses medical marijuana tests positive, the employer is
still required to follow the agency regulations with regards to the positive
drug test.
DEPARTMENT OF JUSTICE APPROACH TO MEDICAL
MARIJUANA
Memorandum from David W. Ogden, Deputy Attorney General,
For Selected U.S. Attorneys (Oct. 19 2009), available at
http://www.justice.gov/sites/default/files/opa/legacy/2009/10/19/medical
-marijuana.pdf.
This is the first memorandum issued by the Department of Justice with
regards to medical marijuana. It explains that the Department is adopting a
policy where it will focus enforcement activity on “significant traffickers
and trafficking networks,” not individuals suffering from debilitating diseases, such as cancer.
Memorandum from James M. Cole, Deputy Attorney General,
For
U.S.
Attorneys
(Jun.
29,
2011),
available
at
http://www.mpp.org/assets/pdfs/library/Cole-memo.pdf.
This is the second memorandum issued by the Department of Justice
with regards to medical marijuana. Here, the Department takes the position
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that it is still committed to enforcing the Controlled Substances Act. This
memo outlines that it was not the Department’s intention to protect largescale cultivators from federal prosecution. Rather, the first memorandum
was merely intended to protect users of medical marijuana, and to ensure
that federal resources were directed to large-scale operations.
Memorandum from James M. Cole, Deputy Attorney General,
For
U.S.
Attorneys
(Aug.
29,
2013),
available
at
http://www.justice.gov/iso/opa/resources/3052013829132756857467.pdf.
This is the third memorandum issued by the Department of Justice
with regards to medical marijuana. Here, the Department once again reiterated its priorities with regards to medical marijuana and enforcing the Controlled Substance Act. The memorandum outlines several areas that the
Department is interested in, such as large scale trafficking and the sale of
marijuana to minors. The Department expressed that it was not interested in
pursuing individual medical marijuana users.
Robert A. Mikos, A Critical Appraisal of the Department of Justice’s New
Approach to Medical Marijuana, 22 STAN. L. & POL’Y REV. 633 (2011).
This Article examines the true impact of the Department of Justice’s
(DOJ) new approach to prosecuting medical marijuana at the federal level–
the non-enforcement approach. The author argues that on its face the approach appears to be groundbreaking and ceding power to the states to
regulate medical marijuana. However, upon closer examination the nonenforcement approach does not really do anything. First, the author provides a brief history on state and federal medical marijuana laws and the
federal government’s enforcement response. Next, the author looks at
whether the DOJ’s approach actually stops criminal prosecutions. He concludes that it does not for two reasons. First, because the DOJ did not create
an enforceable right, and second, the DOJ does not have the power to monitor and sanction its own employees for failing to comply with the new approach. Next, the author explores some of the civil actions that may be taken by other federal agencies, private citizens, and state officials. Finally, the
author concludes that if criminal prosecutions are truly going to be curbed
the federal government must legalize marijuana.
FAMILY LAW AND MEDICAL MARIJUANA
David Malleis, Comment, The High Price of Parenting High: Medical Marijuana and its Effects on Child Custody Matters, 33 U. LA VERNE L. REV.
357 (2012).
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In this Article, the author addresses the challenges faced in permitting
the medicinal use of marijuana in connection with family and custody issues. The author notes that several states permit the use of medical marijuana without producing a negative impact on the medical marijuana user’s
parental rights. Mr. Malleis summarizes the history of marijuana use ranging from recreational to religious to medicinal. A brief overview of state
law and the Controlled Substances Act is provided along with a brief discussion of Gonzales v. Raich and U.S. Attorney General Eric Holder’s
guidelines concerning the enforcement of federal law in medical marijuana
use instances. In addressing family law issues, the author presents three
approaches in child custody cases. The approaches identified are: 1) “The
Best Interest of the Child;” 2) “The Hybrid Conduct Standard,” which provides for the protection of parental rights “unless the person’s conduct creates an unreasonable danger” (the author notes that some states have legislated this position while others have arrived there through judicial action);
and 3) “The Per Se Probative Standard.” The author applies the two latter
standards to a custody issue and discusses the possible outcomes. He also
compares pros and cons of the standards concluding the “Hybrid Conduct
Standard” is superior.
ATTORNEY ETHICAL ISSUES AND MEDICAL MARIJUANA
Sam Kamin & Eli Wald, Marijuana Lawyers: Outlaws or Crusaders?, 91
OR. L. REV. 869 (2013).
The authors address the issues faced by attorneys representing people
and entities in the lawful use and provision of medical marijuana, and in
some states legal recreational use, businesses. Much of the conflict arises
due to the fact that at the federal level marijuana is an illegal drug. In their
discussion of federalism the authors note that the Controlled Substances Act
clearly does not preempt regulation of marijuana. The Department of Justice memorandum regarding enforcement is discussed and it is suggested
that the memo does not state that enforcement will not occur in states having adopted medical marijuana laws. The second Department of Justice
memorandum on topic, the authors indicate, supports the view that the first
memorandum was misinterpreted. Highlighting this misinterpretation were
acts of the United States Attorney’s office indicting marijuana cooperatives
and sending cease and desist letters to dispensaries. Additional issues arise,
for example, where residents in public housing indicate that they will not
violate criminal laws, or parolees who agree to not use controlled substances yet the states in which they reside permit medical marijuana use and in
some instances recreational use. In covering the representation of medical
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marijuana, client issues such as accomplice and coconspirator liability are
discussed. The authors provide an analysis of actions where attorneys were
found to be aiding criminal clients and they also identify the chilling effect
such actions can have on the effective representation of criminal clients.
With respect to the Controlled Substances Act and coconspirator or accomplice liability the authors indicate that there needs to be shown a mens rea
of true intent. Also covered are ethical considerations when representing
marijuana clients. The authors look at ABA Model Rule of Professional
Conduct 1.2(d) in the discussion of ethical concerns. The rule, the authors
indicate, permits an attorney to discuss medical marijuana and explain the
potential Controlled Substances Act issues, but does not allow the drafting
of documents related to the client’s business. The differing ethical application stances in Arizona and Maine are also covered. An attorney’s status as
a medical marijuana patient is looked at in the ethical considerations as
well. Financial activities in the medical marijuana industry by lawyers, as
well as, legal services that may be permitted to be provided by attorneys in
the area are addressed. There are also sections on questionable and prohibited legal services.
Alec Rothrock, Is Assisting Medical Marijuana Dispensaries Hazardous to
a Lawyer’s Professional Health?, 89 DENV. U.L. REV. 1047 (2012).
The author examines Colorado Rule of Professional Conduct 1.2(d) in
light of an attorney providing legal services to a medical marijuana dispensary. While doing so is not a violation of Colorado law, the author notes it
is a violation of federal law and thus creates a conflict with this rule. He
also identifies ethics opinions from Maine and Arizona that reach opposite
conclusions in their interpretation of Rule 1.2(d) with respect to medical
marijuana activities. The author provides a discussion of good faith arguments and provides examples outside the medical marijuana realm. Mr.
Rothrock identifies other prohibitions from Rule 1.2(d) including counseling and assisting. He also discusses the knowledge requirement of the rule.
He states that no Colorado lawyers have been publicly disciplined; however, under the rule it is possible and no disciplinary action thus far does not
mean it will not happen.
MODEL RULES OF PROFESSIONAL CONDUCT R. 1.2
Client-Lawyer Relationship
Scope of Representation and Allocation of Authority between Client
and Lawyer
(a) Subject to paragraphs (c) and (d), a lawyer
shall abide by a client’s decisions concerning the
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objectives of representation and, as required by
Rule 1.4, shall consult with the client as to the
means by which they are to be pursued. A lawyer
may take such action on behalf of the client as is
impliedly authorized to carry out the representation. A lawyer shall abide by a client's decision
whether to settle a matter. In a criminal case, the
lawyer shall abide by the client's decision, after
consultation with the lawyer, as to a plea to be entered, whether to waive jury trial and whether the
client will testify.
(b) A lawyer’s representation of a client, including representation by appointment, does not
constitute an endorsement of the client’s political,
economic, social or moral views or activities.
(c) A lawyer may limit the scope of the representation if the limitation is reasonable under the
circumstances and the client gives informed consent.
(d) A lawyer shall not counsel a client to engage, or assist a client, in conduct that the lawyer
knows is criminal or fraudulent, but a lawyer may
discuss the legal consequences of any proposed
course of conduct with a client and may counsel or
assist a client to make a good faith effort to determine the validity, scope, meaning or application of
the law.

STATE REGULATORY ACTIONS
Peter J. Cohen, Medical Marijuana 2010: It’s Time to Fix the Regulatory
Vacuum, 38 J.L. MED. & ETHICS 654 (2010).
The author starts by discussing the roadblock to effective research on
the medicinal uses of marijuana imposed by its classification as a Schedule
I drug in the Controlled Substances Act. He provides examples of the Drug
Enforcement Agency and the National Institute of Drug Abuse not permitting access to marijuana by university researchers, thus hampering their
abilities to develop scientific information on the efficacy of medical marijuana. Also discussed is the attempt in the 1990s by scientists to have the
Drug Enforcement Agency permit such research. In 1999 the National
Academies of Sciences’ Institute of Medicine proceedings included materials indicating that marijuana had beneficial effects in dealing with chemo-
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therapy related nausea, AIDS, wasting syndrome, and some types of spasticity among other conditions. Yet, these findings were not considered by
the agencies. He indicates that the American Medical Association even
recommended a review of the Schedule I classification of marijuana in order to allow for a relaxation on access to cannabis for research purposes.
All of the scientific and medical groups that supported a scientific evaluation of the potential use of marijuana for medical purposes were not heeded
by the federal entities able to affect the start of a change. The author provides a discussion of marijuana as a gateway drug. Mr. Cohen provides an
overview of state attempts at regulating marijuana and focuses on California and Colorado. He then proposes revisions to state regulations to better
oversee the practices related to medical marijuana. Among those is the participation of physicians as “therapeutic gatekeepers” and state boards of
medicine providing oversight. He concludes by reiterating the need for scientific evidence to be the basis of approval of any drug for medicinal use
and indicates such evidence exists with respect to marijuana.
Robert A. Mikos, On the Limits of Supremacy: Medical Marijuana and the
States’ Overlooked Power to Legalize Federal Crime, 62 VAND. L. REV.
1421 (2009).
The author looks at the strong position of the states to legalize activities that are banned by the federal government. While his Article focuses on
medical marijuana he also indicates this approach is possible in other areas
as well. A basis for this argument is that the states are permitting behavior
(not acting with respect to it) that is banned by the federal government. Mr.
Mikos provides an overview of state laws at the time of writing and the
Controlled Substances Act and its constitutionality. Despite the holding in
Gonzales v. Raich, the author does not find federal law to preempt the
states’ legalization of medical marijuana. He provides an explanation for
this by looking at the anti-commandeering doctrine and how it constrains
the preemption power, and the congressional intent seen in the Controlled
Substances Act limiting the preemptive powers of the Act. Additionally, the
author looks at five types of state statutes with respect to legalized medical
marijuana and discusses why these laws are likely not preempted. Mr.
Mikos also looks at ways Congress can try to alter the state laws and
whether these methods are appropriate or realistic. The author also provides
a discussion of why people obey laws and how that factors into this area.
Karen O’Keefe, State Medical Marijuana Implementation and Federal Policy, 16 J. HEALTH CARE L. & POL’Y 39 (2013).
The author in looking at efforts to “reschedule marijuana under federal
law,” looks at state marijuana laws and the interaction of state policies and

2015]

MEDICAL MARIJUANA: AN ANNOTATED BIBLIOGRAPHY

501

federal law in the states that have legalized marijuana. Ms. O’Keefe addresses the Schedule I Controlled Substances Act classification of marijuana and the unwillingness over the years of the Drug Enforcement Agency
and the Food and Drug Administration, with support from the federal
courts, to change the classification. She notes this resistance in the face of
much research showing the effectiveness and safety of marijuana. She looks
at early state legislative attempts to recognize the value of medical marijuana. Such laws permitted marijuana as a prescription, but doctors could not
prescribe marijuana without potential sanctions and pharmacies could not
fill such prescriptions under federal law. Other laws provided federal approval for small-scale programs. She covers more recent actions to legalize
medical marijuana starting with California’s 1996 law that did not rely on
any help or consent from the federal government. She summarizes the California law as well as identifies other states that subsequently enacted medical marijuana laws. Also identified are instances where states chose not to
enforce federal laws. Ms. O’Keefe moves on to discuss the growth of dispensaries and federal impediments to these entities. She then discusses the
start of regulated dispensaries with the 2008 New Mexico law and subsequent states legalizing medical marijuana and regulating its distribution to
some extent. She concludes by identifying ways to more closely align federal and state policies.

MISCELLANEOUS
D. Mark Anderson, Benjamin Hansen, & Daniel I. Rees, Medical Marijuana Laws, Traffic Fatalities, and Alcohol Consumption, 56 J.L. & ECON. 333
(2013).
This Article examines the impact of legalized medical marijuana on
road fatalities. In addition, the authors look at whether or not legalized medical marijuana works as a replacement for overall alcohol consumption.
First, the authors provide a brief history of marijuana in the United States;
they begin with the introduction of marijuana in the early 1660s and end
with the 1996 passage of California’s medical marijuana statute. Next, the
authors briefly discuss driver impairments associated with alcohol or marijuana use. The authors concluded that while marijuana does impair drivers,
alcohol impaired drivers tend to take more risks and underestimate their
level of impairment. The authors also discuss the impact medical marijuana
laws have on the marijuana market. The authors conclude that medical marijuana laws lead to a substantial decrease in the price of high-grade marijuana. In addition, the demand for high-grade medical marijuana steadily increases, especially among users who are under the legal age limit to consume alcohol. The authors argue that this has a direct impact on the drop in
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traffic fatalities for this age group. They assert that users in this age group
replace alcohol with marijuana and this in turn leads to fewer fatalities because marijuana users are better drivers than their counterparts using alcohol. They also assert that alcohol use tends to take place at restaurants and
bars, requiring people to drive impaired, whereas marijuana users tend to
consume it in the home.
Peter J. Cohen, Medical Marijuana: The Conflict between Scientific and
Political Ideology, 2009 UTAH L. REV. 35 (2009).
Mr. Cohen provides an overview of the FDA and its role in investigating drugs for the legal drug market. Within that overview he identifies issues such as the difference in purpose and effect of medicinal and recreational use of marijuana. He also addresses arguments regarding the negative
side effects and risks associated with marijuana use while also showing
similar, and in some instances, greater risks existing with other authorized
controlled substances used in medicine. Mr. Cohen spends some time
speaking to risks such as the connection between smoking marijuana and
pulmonary cancer, the possibility that marijuana use leads to the use of other illegal drugs–the “Gateway Hypothesis,” and uses related legal and scientific materials to support his arguments. Additionally, the author provides
a summary of the history of medical marijuana’s use prior to the passage of
legislation making it an illegal substance and recent studies showing its
medicinal applications and benefits. In the latter part of the Article he addresses the struggles faced due to differing scientific and political perceptions of the use of marijuana as a medicine, including its designation as a
Schedule I controlled substance and how that affects its designation for use
in medical situations, especially when smoked. Mr. Cohen also presents
information on the use of Dronabinol and Sativex™ and compares their use
and effects to smoked marijuana.
Moira Gibbons, The Cannabis Conundrum: Medication v. Regulation,
HEALTH LAW, Dec. 2011, at 1.
The author educates the readers on the make-up of cannabis and the
ways in which the marijuana plant is used. She also explains cannabinoids
and among them THC. Ms. Gibbons explains how a medicine is chosen for
treatment and the lack of studies on medical marijuana to assist in it fitting
into that choice process. She identifies an Institute of Medicine report often
cited by the Drug Enforcement Agency to justify keeping the ban on marijuana. She also identifies new drugs developed to help in areas such as
chemotherapy-induced nausea. She indicates though that the efficacy of
these compared to medical marijuana has not been compared. She states
that research on plant and synthetic cannabinoids needs to continue. Some
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of the barriers to these are the roadblocks to obtaining marijuana via government systems and the lack of consistency in the marijuana used. The
author proceeds to provide an overview of the federal stance on medical
marijuana followed by a summary of state actions in this area.
John Dwight Ingram, Medical Use of Marijuana, 33 OKLA. CITY U. L.
REV. 589 (2008).
The author summarizes briefly Gonzales v. Raich. He then addresses
actions in the states regarding medical marijuana pointing out language
from the California law. He then moves on to discuss the Controlled Substances Act and the federal government’s “war on drugs.” A more in-depth
discussion of Gonzales v. Raich is followed by a discussion of legalizing
medical marijuana. He suggests several possible ways to do so. These include: 1) rescheduling marijuana; 2) amending the Controlled Substances
Act; or 3) bringing a new case before the U.S. Supreme Court that changes
the stance taken in Gonzales v. Raich.
Sam Kamin, The Limits of Marijuana Legalization in the States, 99 IOWA
L. REV. 39 (2014).
This Article explores the pitfalls of medical marijuana with regards to
running a business. The author traces this back to the core federalism issue—the states are trying legalize something that is not in their power to
legalize. The Article not only briefly maps out the federalism issue and
explores how the Department of Justice Memorandums muddy the issue,
but it also explores several legal and business areas that are particularly
affected by this issue. These areas are: employment law, probation/parole
rules, contracting, and banking. The author argues that until the federalism
issue is resolved in a meaningful way, medical marijuana will never be able
to become a legitimate tax generating part of the economy.
Linda Simoni-Wastila & Francis B. Palumbo, Medical Marijuana Legislations: What We Know - and Don’t, 16 J. HEALTH CARE L. & POL’Y 59
(2013).
In this Article the authors review medical marijuana policies and laws
and provide suggestions for the evaluation of medical marijuana laws and
their implementation. Also covered are the known and unknown health
outcomes as well as the identification of knowledge gaps in areas such as
social outcomes, dispensary models, and data collection. The data collection limitations are highlighted by the authors who indicate their belief that
the best course would be a database analyzing medical marijuana on a
number of levels including medical, social, and criminal, among others. The
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authors recommend further study of best models for dispensaries and provide potential models. The authors discuss Risk Evaluation and Mitigation
Strategies of the Food and Drug Administration and indicate that medical
marijuana would be a good candidate for this. Also provided is a discussion
of participation in drug monitoring programs.
William Vertes & Sarah Barbantini, Caught in the Crossfire: The Dilemma
of Marijuana “Medicalization” for Healthcare Providers, 58 WAYNE L.
REV. 103 (2012-2013).
The authors provide a history of marijuana use dating back to 1500
B.C., when the Chinese used it for medicinal purposes. They also point to
its inclusion in the United States Pharmacopeia in the 1950s. The change in
perception of marijuana and its move to a controlled substance is chronicled. The classification of substances as “drugs” and the categories into
which drugs fall under the Comprehensive Drug Abuse Control Act is reviewed along with whether medical marijuana falls within the second category. The Controlled Substances Act is discussed with a summary of the
process for modification of a drug placed within the Controlled Substances
Act’s five schedules. Additionally, the authors discuss what a medicine is
and whether separate from being a drug is marijuana a medicine. A discussion is also presented on the benefits and pitfalls to both sides if marijuana
were reclassified or remained on Schedule I of the Controlled Substances
Act. For example, the current models do not involve licensed pharmacists,
but rather medical marijuana is self-grown, obtained from a caregiver, or
through a dispensary, whereas reclassification as a prescription would involve working through a pharmacist. A significant portion of the work focuses on the Michigan Medical Marijuana Act. In discussing the Michigan
Act the authors note the requirement of a physician’s evaluation for a registry card and the fact that a physician cannot prescribe marijuana because of
its lack of recognition for medical use. Also noted is the Act’s requirement
of a bona-fide physician-patient relationship without defining the term,
however they note subsequent legislation was introduced to help clarify this
area. Additionally, the requirements of the Board of Health Professionals
with respect to physicians certifying patients for medical marijuana use
provide clarification.
Michael Vitiello, Why the Initiative Process is the Wrong Way to Go: Lessons We Should Have Learned from Proposition 215, 43 MCGEORGE L.
REV. 63 (2012).
The author provides a history of California’s Proposition 215, which
legalized medical marijuana use in the state, from before its enactment
when the federal government had the Compassionate Use Program in effect
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to its passage and subsequent legislative and judicial actions. The author
covers what he terms “drafting problems” with the initiative. Among those
he includes the lack of information on where to obtain marijuana, the ambiguous definition of terms such as “primary caregiver,” and the initiative’s
lack of defenses for actions such as transporting marijuana. He indicates
how, over the years, courts and the legislature have had to address issues
not originally addressed by the proposition such as defining a physician’s
recommendation or approval and defining a caregiver. The author summarizes the 2004 Medical Marijuana Program Act and how it resolved some of
the initial issues presented by Proposition 215. He also covers 2008 guidelines from the state Attorney General that provided guidance the author
indicates was needed twelve years earlier, including regulation guidelines
for dispensaries. In addressing his main contention that the initiative process is not the way to bring about laws, the author identifies the following
concerns: 1) the proposition resulted from a manipulation of the initiative
process rather than through true debate; 2) the initiative process limits the
ability of the legislature to reform the law if the proposed legislation is not
consistent with the initiative; and 3) in the case of Proposition 215 the
“chaos” of the previous fifteen years had led to human and economic costs.
In discussing whether it is worthwhile to continue a discussion of the legalization of medical marijuana he identifies the strong support for doing so,
which is unlike support for any other drug. Another factor he looks at is the
positive economic effect legalization might have in many jurisdictions,
while also identifying additional possible costs that will come about from
legalization. Also identified by the author as tipping the scale toward legalization is the large number of persons incarcerated in the United States for
drug related offenses. He then provides a look at the possible means by
which to legalize marijuana.

NEWSPAPER COVERAGE
The following section provides a brief list of newspaper articles from
the last year addressing various aspects of the medical marijuana debate.
RECENT NEW YORK TIMES ARTICLES
Judge Limits Medical Marijuana Delivery App, N.Y. TIMES (Dec. 23,
2014),
http://www.nytimes.com/aponline/2014/12/23/us/ap-us-medicalmarijuana-delivery-app.html?_r=0.
Los Angeles County voted to ban marijuana delivery services. A judge
in the Los Angeles County Superior Court issued a preliminary injunc-
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tion against the developers of an app that provided delivery of marijuana.
Medical Marijuana a Challenge for Legal Pot States, N.Y. TIMES (Jan. 2,
2015), http://www.nytimes.com/aponline/2015/01/02/us/ap-us-rethinkingpot-a-year-later.html.
Looks at the challenges of states with legalized recreational use and
the issues with taxes and “black market sales.”
Princeton Worker Put on Leave over Medical Pot, N.Y. TIMES (Sept. 2,
2014), http://www.nytimes.com/aponline/2014/09/02/us/ap-us-princetonmarijuana-ultimatum.html.	
  
	
  
Ian Lovett, Berkley Pushes a Boundary on Medical Marijuana, N.Y. TIMES
(Sept. 2, 2014), http://www.nytimes.com/2014/09/03/us/03berkeley.html.
The article discusses the effort in Berkley to provide medical marijuana to low income residents.
STATES DIFFERENT ACTIONS ON MEDICAL MARIJUANA
Florida Medical Marijuana Backers Seek Law, Ballot Drive in 2016, N.Y.
TIMES (Jan. 9, 2015),
http://www.nytimes.com/reuters/2015/01/09/us/politics/09reuters-usaflorida-marijuana.html.
Illinois Legalizes Medical Marijuana for Children with Seizures, N.Y.
TIMES (July 20, 2014),
http://www.nytimes.com/reuters/2014/07/20/us/20reuters-usa-illinoiscannabis.html.
North Carolina Joins States Allowing Limited Medical Marijuana, N.Y.
TIMES (July 3, 2014),
http://www.nytimes.com/reuters/2014/07/03/us/politics/03reuters-usanorthcarolina-marijuana.html.
INTERNATIONAL ACTIONS ON MEDICAL MARIJUANA
Brazil to Study Legalization of Medical Marijuana, N.Y. TIMES (Dec. 19,
2014), http://www.nytimes.com/aponline/2014/12/19/world/americas/ap-ltbrazil-medical-marijuana.html.
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Chilean Moms Growing Support for Medical Marijuana, N.Y. TIMES (Nov.
24, 2014),
http://www.nytimes.com/aponline/2014/11/24/world/americas/ap-lt-chilemarijuana-moms.html.
Columbia’s Senate Moves to Pass Medical Marijuana, N.Y. TIMES (Nov.
12, 2014),
http://www.nytimes.com/aponline/2014/11/12/world/americas/ap-ltcolombia-medical-marijuana.html.
RECENT HUFFINGTON POST ARTICLES
Rachelle Friedman, Bill to Legalize Medical Marijuana in Pennsylvania
has Bipartisan Support for First Time Ever, HUFFINGTON POST (Feb. 24,
2014), http://www.huffingtonpost.com/2014/02/26/pennsylvaniamarijuana-legal-medical-first-time-ever-bipartisansupport_n_4855753.html
Hunter Stewart, Minnesota Wants to Legalize Medical Marijuana, But Police Agencies are in the Way, HUFFINGTON POST (Feb. 24, 2014),
http://www.huffingtonpost.com/2014/02/24/minnesotamarijuana_n_4847825.html.
Gary Stein, God Becomes a Passive Lobbyist for Medical Marijuana,
HUFFINGTON POST (Feb. 24, 2014), http://www.huffingtonpost.com/garystein/god-becomes-a-passive-lobbyist_b_4824659.html.
The 420 Times, Washington Lawmakers Vote to Revise Medical Marijuana
Regulations, HUFFINGTON POST (Feb. 20, 2014),
http://www.huffingtonpost.com/the-/washington-lawmakersvote_b_4821108.html.
Matt Ferner, Epilepsy Group Announces Support for Medical Marijuana,
HUFFINGTON POST (Feb. 20, 2014),
http://www.huffingtonpost.com/2014/02/20/epilepsy-foundation-medicalmarijuana_n_4825734.html.
Christopher Mathias, New York Moves Closer To Legalizing Medical Marijuana, HUFFINGTON POST (Feb. 20, 2014),
http://www.huffingtonpost.com/2014/02/20/new-york-medicalmarijuana_n_4818205.html.
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Illinois’ Proposed Medical Marijuana Rules Could Squeeze out Small
Businesses, HUFFINGTON POST (Feb. 14, 2014),
http://www.huffingtonpost.com/2014/02/14/illinois-medical-marijuanarules_n_4789742.html.
Matt Ferner, Number of Children Seeking Medical Marijuana Soars in Colorado, HUFFINGTON POST (Feb. 13, 2014),
http://www.huffingtonpost.com/2014/02/13/medical-marijuanachildren_n_4768219.html.
Hunter Stewart, Kentucky Considers Legalizing Medical Marijuana,
HUFFINGTON POST (Feb. 11, 2014),
http://www.huffingtonpost.com/2014/02/10/kentucky-marijuana-medicalbill_n_4762497.html.
Russ Belville, NRA Quiet on Disarming Legal Medical Marijuana Patients,
HUFFINGTON POST (Feb. 7, 2014), http://www.huffingtonpost.com/russbelville/nra-medical-marijuana_b_4740222.html.
RECENT CHICAGO TRIBUNE ARTICLES
Chuck Fieldman, Medical Marijuana Has Several Uses, Says Oak Brook
Doctor, CHI. TRIB. (Feb. 9, 2015),
http://www.chicagotribune.com/suburbs/oak-brook/news/ct-dob-moymarijuana-tl-0212-20150209-story.html.
Mike Danahey et al., State Passes on Medical Marijuana Dispensary in
Elgin, CHI. TRIB. (Feb. 9, 2014),
http://www.chicagotribune.com/suburbs/elgin-courier-news/news/ct-ecnelgin-med-pot-st-0204-20150209-story.html#page=1.
Robert McCoppin, Two Chicago Medical Marijuana Store Licenses Approved, CHI. TRIB. (Feb. 7, 2015), http://www.chicagotribune.com/news/ctmedical-marijuana-dispensary-license-met-20150206-story.html.
Marwa Eltagouri, State Rejects Proposal for Batavia Medicinal Pot Cultivation Center, CHI. TRIB. (Feb. 6, 2015),
http://www.chicagotribune.com/suburbs/batavia-geneva-st-charles/news/cttri-medical-marijuana-dispensary-rejected-batavia-tl-0212-20150206story.html.
Rick Kambic, Mundelein Lands All 3 Medical Marijuana Dispensaries in
Lake County, CHI. TRIB. (Feb. 5, 2015),
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http://www.chicagotribune.com/suburbs/mundelein/news/ct-mun-medicalmarijuana-tl-0212-20150205-story.html.
Robert McCoppin, State Approves 1,000 for Medical Pot; Drug Access
Remains Months Away, CHI. TRIB. (Feb. 4, 2015),
http://www.chicagotribune.com/news/local/breaking/ct-medical-marijuanaillinois-1000-patients-met-20150204-story.html.
Susan Frick Carlman, Medical Pot OK Includes Naperville Site, CHI. TRIB.
(Feb. 3, 2015), http://www.chicagotribune.com/suburbs/napervillesun/news/ct-nvs-medical-marijuana-rauner-st-0204-20150203-story.html.
Ellen Jean Hirst et al., For Illinois Businesses that Won Medical Pot Permits, Anticipation Grows, CHI. TRIB. (Feb. 3, 2015),
http://www.chicagotribune.com/business/ct-illinois-medical-marijuana0204-biz-20150203-story.html.
Alex V. Hernandez, Medical Marijuana Shop Gets state’s OK to Open in
Oak Park, CHI. TRIB. (Feb. 3, 2015),
http://www.chicagotribune.com/suburbs/oak-park/news/ct-oak-marijuanatl-0212-20150203-story.html.

